142 related articles for article (PubMed ID: 37946295)
1. Downregulation of pro-surfactant protein B contributes to the recurrence of early-stage non-small cell lung cancer by activating PGK1-mediated Akt signaling.
Luo H; Li Q; Wang RT; Zhang L; Zhang W; Deng MS; Luo YY; Ji X; Wen Y; Zhou XR; Xu B; Wang D; Hu B; Jin H; Xu CX
Exp Hematol Oncol; 2023 Nov; 12(1):94. PubMed ID: 37946295
[TBL] [Abstract][Full Text] [Related]
2. Gene polymorphisms of SFTPB rs7316, rs9752 and PAOX rs1046175 affect the diagnostic value of plasma Pro-SFTPB and DAS in Chinese Han non-small-cell lung cancer patients.
Wang K; Huang Q; Zhao G; Yang J; Yang K; Huang Y
J Cell Biochem; 2019 Sep; 120(9):14804-14812. PubMed ID: 31016788
[TBL] [Abstract][Full Text] [Related]
3. OTUB2 stabilizes U2AF2 to promote the Warburg effect and tumorigenesis via the AKT/mTOR signaling pathway in non-small cell lung cancer.
Li J; Cheng D; Zhu M; Yu H; Pan Z; Liu L; Geng Q; Pan H; Yan M; Yao M
Theranostics; 2019; 9(1):179-195. PubMed ID: 30662561
[TBL] [Abstract][Full Text] [Related]
4. Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non-Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B.
Wikoff WR; Hanash S; DeFelice B; Miyamoto S; Barnett M; Zhao Y; Goodman G; Feng Z; Gandara D; Fiehn O; Taguchi A
J Clin Oncol; 2015 Nov; 33(33):3880-6. PubMed ID: 26282655
[TBL] [Abstract][Full Text] [Related]
5. Rab11-FIP2 suppressed tumor growth via regulation of PGK1 ubiquitination in non-small cell lung cancer.
Dong W; Li H; Wu X
Biochem Biophys Res Commun; 2019 Jan; 508(1):60-65. PubMed ID: 30471866
[TBL] [Abstract][Full Text] [Related]
6. PGK1 contributes to tumorigenesis and sorafenib resistance of renal clear cell carcinoma via activating CXCR4/ERK signaling pathway and accelerating glycolysis.
He Y; Wang X; Lu W; Zhang D; Huang L; Luo Y; Xiong L; Li H; Zhang P; Li Q; Liang S
Cell Death Dis; 2022 Feb; 13(2):118. PubMed ID: 35121728
[TBL] [Abstract][Full Text] [Related]
7. Expression and clinical significance of the phosphatidylinositol 3-kinase/protein kinase B signal transduction pathway in non-small cell lung carcinoma.
Jiang AG; Yu H; Huang JA
Oncol Lett; 2014 Aug; 8(2):601-607. PubMed ID: 25013474
[TBL] [Abstract][Full Text] [Related]
8. TIPE3 promotes non-small cell lung cancer progression via the protein kinase B/extracellular signal-regulated kinase 1/2-glycogen synthase kinase 3β-β-catenin/Snail axis.
Li Q; Yu D; Yu Z; Gao Q; Chen R; Zhou L; Wang R; Li Y; Qian Y; Zhao J; Rosell R; Tao M; Xie Y; Xu C
Transl Lung Cancer Res; 2021 Feb; 10(2):936-954. PubMed ID: 33718034
[TBL] [Abstract][Full Text] [Related]
9. Pro-surfactant protein B as a biomarker for lung cancer prediction.
Sin DD; Tammemagi CM; Lam S; Barnett MJ; Duan X; Tam A; Auman H; Feng Z; Goodman GE; Hanash S; Taguchi A
J Clin Oncol; 2013 Dec; 31(36):4536-43. PubMed ID: 24248694
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non-small cell lung cancer patients.
Liao L; Yu H; Ge M; Zhan Q; Huang R; Ji X; Liang X; Zhou X
Thorac Cancer; 2019 May; 10(5):1203-1212. PubMed ID: 30977310
[TBL] [Abstract][Full Text] [Related]
11. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P
Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253
[TBL] [Abstract][Full Text] [Related]
12. Serum pro-surfactant protein B is correlated with clinical properties in osteosarcoma patients.
Feng S; Fu D; Zhang Y; Zhang L; Ji Y; Li H; A L
Biochem Cell Biol; 2023 Oct; 101(5):456-463. PubMed ID: 37192548
[TBL] [Abstract][Full Text] [Related]
13. The miR-23a/27a/24-2 cluster promotes postoperative progression of early-stage non-small cell lung cancer.
Fan X; Tao S; Li Q; Deng B; Tan QY; Jin H
Mol Ther Oncolytics; 2022 Mar; 24():205-217. PubMed ID: 35071744
[TBL] [Abstract][Full Text] [Related]
14. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
[TBL] [Abstract][Full Text] [Related]
15. Plasma pro-surfactant protein B and lung function decline in smokers.
Leung JM; Mayo J; Tan W; Tammemagi CM; Liu G; Peacock S; Shepherd FA; Goffin J; Goss G; Nicholas G; Tremblay A; Johnston M; Martel S; Laberge F; Bhatia R; Roberts H; Burrowes P; Manos D; Stewart L; Seely JM; Gingras M; Pasian S; Tsao MS; Lam S; Sin DD;
Eur Respir J; 2015 Apr; 45(4):1037-45. PubMed ID: 25614175
[TBL] [Abstract][Full Text] [Related]
16. Aberrantly High Expression Of NOK/STYK1 Is Tightly Associated With The Activation Of The AKT/GSK3β/N-Cadherin Pathway In Non-Small Cell Lung Cancer.
Huang Z; Ma N; Xiong YL; Wang L; Li WM; Lai YY; Zhang CX; Zhang ZP; Li XF; Zhao JB
Onco Targets Ther; 2019; 12():10299-10309. PubMed ID: 31819514
[TBL] [Abstract][Full Text] [Related]
17. Elevated expression of G3BP1 associates with YB1 and p-AKT and predicts poor prognosis in nonsmall cell lung cancer patients after surgical resection.
Zheng H; Zhan Y; Zhang Y; Liu S; Lu J; Yang Y; Wen Q; Fan S
Cancer Med; 2019 Nov; 8(16):6894-6903. PubMed ID: 31560169
[TBL] [Abstract][Full Text] [Related]
18. GPX2 promotes EMT and metastasis in non-small cell lung cancer by activating PI3K/AKT/mTOR/Snail signaling axis.
Peng F; Xu Q; Jing X; Chi X; Zhang Z; Meng X; Liu X; Yan J; Liu X; Shao S
FASEB Bioadv; 2023 Jun; 5(6):233-250. PubMed ID: 37287867
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary surfactant-associated protein B regulates prostaglandin-endoperoxide synthase-2 and inflammation in chronic obstructive pulmonary disease.
Wang Y; Gao X; Li Y; Wang X; Li Y; Zhang S; Liu H; Guo H; Lu W; Sun D
Exp Physiol; 2021 May; 106(5):1303-1311. PubMed ID: 33729612
[TBL] [Abstract][Full Text] [Related]
20. PGK1 facilities cisplatin chemoresistance by triggering HSP90/ERK pathway mediated DNA repair and methylation in endometrial endometrioid adenocarcinoma.
Zhou JW; Tang JJ; Sun W; Wang H
Mol Med; 2019 Mar; 25(1):11. PubMed ID: 30925862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
